Bg pattern

TARDYFERON 80 mg PROLONGED-RELEASE TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

5.0 (53)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TARDYFERON 80 mg PROLONGED-RELEASE TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Tardyferon 80 mg comprimidos de liberación prolongada

Hierro (en forma de sulfato ferroso desecado)

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
    • Si tiene alguna duda, consulte a su médico o farmacéutico.
    • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
    • Si experimenta efectos adversos, consulte a su médico o farmacéutico incluso si se trata de efectos adversos que no aparecen en este prospecto.Ver sección 4.

Contenido del prospecto

  1. Qué es Tardyferon y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar Tardyferon
  3. Cómo tomar Tardyferon
  4. Posibles efectos adversos
  5. Conservación de Tardyferon
  6. Contenido del envase e información adicional

1. Qué es Tardyferon y para qué se utiliza

Este medicamento contiene hierro de acción prolongada para la prevención y el tratamiento de las anemias ferropénicas y de los estados carenciales de hierro.

Se utiliza en niños con un peso mínimo de 28 kg y en adultos.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Tardyferon

No tome Tardyferon:

  • Si es alérgico al sulfato ferroso o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).
  • Si tiene más hierro en el cuerpo del que necesita.
  • Si tiene un tipo de anemia (cantidad insuficiente de glóbulos rojos) que no es causada por una deficiencia de hierro o que causa una sobrecarga de hierro (por ejemplo, talasemia, anemia refractaria, anemia causada por deficiencia de médula ósea).

Consulte a su médico o farmacéutico si tiene dudas sobre este medicamento.

Advertencias y precauciones

  • Si está tomando este medicamento para una anemia por deficiencia de hierro, también se debe investigar la causa de esta anemia por deficiencia de hierro para poder tratarla.
  • Si la deficiencia de hierro está asociada con el trastorno inflamatorio, el tratamiento con Tardyferon no será eficaz.
  • Consulte a su médico o farmacéutico antes de empezar a tomar este medicamento si tiene dificultades para tragar
  • Basándose en datos de la literatura, se ha observado coloración de la pared gastrointestinal en pacientes de edad avanzada con insuficiencia renal, diabetes (nivel alto de azúcar en la sangre) y/o hipertensión (presión arterial alta) que estaban recibiendo tratamiento para estas enfermedades junto con suplemento de hierro para la anemia. Esta coloración de la pared gastrointestinal puede dificultar la cirugía gastrointestinal. Ante este riesgo, si se programa una cirugía, es recomendable advertir al cirujano de la toma de suplemento de hierro (ver sección 4).
  • Si el medicamento se aspira inadvertidamente (va por el "camino equivocado"), puede entrar en su tracto respiratorio. Si el medicamento entra en contacto con las vías respiratorias, puede provocar lesiones como necrosis (muerte del tejido) o inflamación de los bronquios (lugares por donde pasa el aire a través de los pulmones) o del esófago (el conducto que conecta la boca con el estómago). Estas lesiones pueden causar el estrechamiento de los bronquios. Los signos asociados con tales lesiones pueden incluir: tos persistente, tos con sangre y/o sensación de dificultad para respirar, incluso si la aspiración ocurrió varios días o meses antes de que se presenten estos síntomas.
  • Si el medicamento ha entrado en las vías respiratorias y usted presenta uno o varios de estos síntomas, contacte con su médico o con el servicio de urgencias más cercano lo antes posible para una valoración por un especialista, para asegurarse de que no hay daños en las vías respiratorias.
  • Basándose en datos de la literatura, se han notificado casos de úlcera gástrica abierta y hemorragia gástrica en pacientes tratados con comprimidos de hierro. En ese caso, se recomienda cambiar a una formulación líquida de hierro (ver Sección 4).
  • Debido al riesgo de úlceras en la boca y decoloración de los dientes, los comprimidos no se deben chupar, masticar o dejar en la boca, sino que se tragarán enteros con agua. Si no puede seguir esta indicación o tiene dificultades al tragar, póngase en contacto con su médico.
  • Cuando se está tomando Tardyferon, las heces pueden volverse oscuras. Este efecto es inofensivo.

Niños

Este medicamento no debe administrarse a niños con peso inferior a 28 kg (entre 9-10 años).

Otros medicamentos yTardyferon

Si está tomando los siguientes medicamentos, no tome este medicamento a menos que se lo haya recetado su médico.

De hecho, algunos medicamentos no se pueden usar al mismo tiempo, mientras que otros requieren cambios específicos (por ejemplo, en el momento de la ingesta).

Si toma medicamentos que contienen hierro para inyección, debe evitar tomar Tardyferon.

Si toma los siguientes medicamentos, debe separar su administración con Tardyferon en al menos 2 horas:

  • Determinados antibióticos (ciclinas, fluoroquinolonas, cefdinir)
  • Medicamento para tratar la infección urinaria crónica (ácido acetohidroxámico)
  • Medicamento para tratar la infección por VIH (inhibidores de la integrasa, bictegravir)
  • Medicamentos para tratar la fragilidad ósea u osteoporosis (bifosfonatos)
  • Medicamentos para tratar enfermedades articulares, enfermedad de Wilson o para prevenir cálculos renales (penicilamina, trientina)
  • Medicamentos para tratar acidez estomacal: preparaciones minerales gastrointestinales, carbón o antiácidos (sales de aluminio, calcio y magnesio)
  • Medicamentos para tratar enfermedad de tiroides (tiroxina)
  • Medicamentos para tratar enfermedad de Parkinson (metildopa, levodopa, carbidopa, entacapona)
  • Suplementos y/o medicamentos que contengan zinc o calcio

Si está tomando colestiramina Tardyferon se debe administrar de 1 a 2 horas antes o de 4 a 6 horas después de la administración de colestiramina.

Si está tomando medicamentos con ácido ascórbico (vitamina C) la absorción del hierro puede verse aumentada.

Si está tomando medicamentos con cloranfenicol, éstos pueden retrasar la respuesta al tratamiento con hierro.

Informe a su médico o farmacéutico si está utilizando, o ha utilizado recientemente o pudiera tener que utilizar cualquier otro medicamento, incluso si este es sin receta.

Toma de Tardyferon con alimentos y bebidas

No beba grandes cantidades de té, café, vino tinto porque esto puede disminuir la absorción de hierro en su cuerpo.

No se recomienda tomar este medicamento al mismo tiempo que cereales (salvado, legumbres, cereales oleaginosos), algunas proteínas (huevos) o alimentos o bebidas que contengan calcio (queso, leche, etc.). Dejar un intervalo entre la toma de sales de hierro y estos alimentos (al menos 2 horas).

Embarazo y lactancia

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

No hay estudios específicos en mujeres embarazadas durante el primer trimestre que permitan evaluar el riesgo de malformación. Sin embargo, no se han informado malformaciones congénitas en la literatura ni en la experiencia postcomercialización. Durante el segundo y tercer trimestre se dispone de una gran cantidad de datos bibliográficos sobre mujeres embarazadas que no indican malformaciones ni toxicidad feto/neonatal.

En consecuencia, este medicamento se puede utilizar durante el embarazo si es clínicamente necesario.

Este medicamento se puede utilizar durante la lactancia.

Conducción y uso de máquinas

La influencia del medicamento sobre la capacidad para conducir y utilizar máquinas es nula o insignificante.

Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido, esto es, esencialmente “exento de sodio”.

3. Cómo tomarTardyferon

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Posología:

  • Anemias ferropénicas leves, estados carenciales de hierro y necesidades incrementadas de hierro: 1 comprimido una vez al día, ingerido sin masticar preferiblemente 1 hora antes o 3 horas después de las comidas.
  • Anemias ferropénicas graves, con menos de 8 a 9 g/dl de hemoglobina: 1 comprimido por la mañana y otro por la tarde, durante unas 3 semanas, y a continuación 1 comprimido diario, ingerido sin masticar, preferiblemente 1 hora antes o 3 horas después de las comidas.

Población pediatrica

Este medicamento no debe administrarse a niños con peso inferior a 28 kg (entre 9-10 años).

Duración del tratamiento

La duración del tratamiento dependerá de la gravedad de la deficiencia de hierro, generalmente se requieren por lo menos 3 meses, el tratamiento debe continuar y prolongarse el tiempo necesario para saturar las reservas de hierro guiándose por los parámetros en sangre de corrección de la anemia (Hb, MCV) y la restauración de las reservas de hierro (ferritina sérica, receptor de la transferrina sérica y coeficiente de la saturación de la transferrina).

Forma de administración

Los comprimidos son para uso oral.

Trague los comprimidos enteros con agua. No chupe, mastique o deje el comprimido en la boca.

Los comprimidos deben tomarse con un vaso grande de agua antes o durante las comidas, dependiendo de la tolerancia gastrointestinal (excepto con los alimentos específicos mencionados en la sección "Toma de Tardyferon con alimentos y bebidas").

Si toma más Tardyferon del que debe

En caso de sobredosis o ingestión accidental, consulte inmediatamente a su médico o farmacéutico o llame al Servicio de Información Toxicológica, teléfono 91 562 04 20, indicando el medicamento y la cantidad ingerida.

Los síntomas de sobredosis incluyen signos de irritación gastrointestinal (caracterizados por dolor abdominal, náuseas, vómitos, diarrea y sangrados), que pueden evolucionar a síntomas de acidosis metabólica o shock cardiovascular (caracterizados por respiración rápida o corta, aumento del ritmo cardiaco, dolor de cabeza, confusión, somnolencia, fatiga, falta de apetito, hipotensión, e incluso convulsiones), seguido de insuficiencia renal o hepática hepática.

Si olvidó tomar Tardyferon

Si olvidó tomar un comprimido, tómelo lo antes posible. Sin embargo, si es casi la hora de su próxima dosis, espere la siguiente dosis y luego continúe como de costumbre.

No tome una dosis doble para compensar la dosis olvidada.

Si interrumpe el tratamiento con Tardyferon

No deje de tomar el medicamento hasta el final de su tratamiento. No suspenda el tratamiento antes, aunque se sienta mejor.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Frecuentes (pueden afectar hasta 1 de cada 10 pacientes)

Dificultad para defecar

Diarrea

Agrandamiento abdomen

Dolor abdominal

Heces de color negro

Náuseas

Poco frecuentes (pueden afectar hasta 1 de cada 100 pacientes)

Hinchazón de la garganta (edema de la laringe)

Heces anormales

Indigestión (dispepsia)

Vómitos

Inflamación de la pared del estómago (gastritis)

Picor (prurito)

Erupción cutánea roja (erupción eritematosa)

Frecuencia no conocida (no puede estimarse a partir de los datos disponibles)

Reacción alérgica

Erupción acompañada de picazón (urticaria)

Muerte de células o tejido del pulmón (necrosis pulmonar)*

Inflamación del tejido pulmonar (granuloma pulmonar)*

Estrechamiento de las vías respiratorias (broncostenosis)*

Ulceración de la garganta*

Lesiones esofágicas*

Ulceración esofágica*

Decoloración dental**

Úlceras en la boca**

Descoloración de la pared del tracto gastrointestinal (melanosis gastrointestinal) (ver sección 2)

Úlcera gástrica abierta

Sangrado gástrico (ver sección 2)

  • Todos los pacientes, pero especialmente los pacientes de edad avanzada y los pacientes con dificultades al tragar pueden estar en riesgo de sufrir una úlcera en la garganta, o en el esófago (el conducto que conecta su boca con el estómago. Si el comprimido pasa a las vías respiratorias puede haber riesgo de ulceración de los bronquios (las principales vías de paso de aire de los pulmones) y granuloma pulmonar (inflamación) que puede provocar estrechamiento bronquial.

** En caso de un uso incorrecto, cuando los comprimidos se mastican, se chupan o se dejan en la boca.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de medicamentos de Uso Humano: https://www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Tardyferon

No requiere condiciones especiales de conservación.

Mantener este medicamento fuera de la vista y del alcance de los niños.

No utilice este medicamento después de la fecha de caducidad que aparece en el envase. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia.En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Tardyferon

El principio activo es hierro 80 mg (en forma de sulfato ferroso desecado 247,25 mg).

Los demás componentes son:

  • Núcleo:maltodextrina, celulosa microcristalina, citrato de trietilo, talco, copolímero de metacrilato de amonio tipo B (Eudragit RS 30D), copolímero de metacrilato de amonio tipo A (Eudragit RL 30D)*, dibehenato de glicerol.

*ver sección 2 “Tardyferon contiene”

  • Recubrimiento:dióxido de titanio (E171), sepifilm LP010**, óxido de hierro amarillo (E172), óxido de hierro rojo (E172).

** Composición de Sepifilm LP010: hipromelosa, celulosa microcristalina, ácido esteárico.

Aspecto de Tardyferon y contenido del envase

Comprimidos de liberación prolongada redondos de color rosa anaranjado.

Envase blíster con 30 comprimidos de liberación prolongada.

Titular de la autorización de comercialización

PIERRE FABRE IBÉRICA, S.A.

Ramón Trias Fargas, 7-11

08005 Barcelona

España

Responsable de la fabricación:

Pierre Fabre Médicament Production

Site PROGIPHARM

Rue du Lycée

45500 Gien

Francia

Fecha de la última revisión de este prospecto:06/2024

“La información detallada y actualizada de este medicamento está disponible en la página web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) https://www.aemps.gob.es/”

Online doctors for TARDYFERON 80 mg PROLONGED-RELEASE TABLETS

Discuss questions about TARDYFERON 80 mg PROLONGED-RELEASE TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
0.0 (11)
Doctor

Rita Isabel Calero Garcia

General medicine 2 years exp.

Dr. Rita Isabel Calero Garcia is a physician with extensive experience in emergency medical care, general medicine, and healthcare assistance in various clinical and out-of-hospital settings.

She currently works as a physician at the Canary Islands Emergency Service (Servicio de Urgencias Canario – SUC), where she is responsible for the assessment and care of patients in medical emergency situations, performing the initial diagnosis, patient stabilization, and coordination with hospital services when necessary.

She has also developed her professional activity within the Primary Care Management Service, providing consultations in general medicine. In this setting she is responsible for patient follow-up, management of acute and chronic conditions, as well as health promotion and disease prevention.

She has also worked as a physician in a mobile ICU unit, providing medical assistance in out-of-hospital emergencies, treating critical patients and participating in medicalized patient transport.

In addition, she has collaborated with the Red Cross, participating in healthcare support units, providing medical assistance at events and supporting emergency interventions.

Furthermore, she has provided medical services in the private sector with Salvaser, conducting clinical assessments of patients and providing healthcare services within private medical services.

0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

5.0 (53)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
0.0 (15)
Doctor

Antonio Cayatte

General medicine 44 years exp.

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic. His clinical background includes: 

  • assessment of sudden or unclear symptoms
  • ongoing care for chronic conditions
  • follow-up after hospital discharge
  • interpretation of test results
  • medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association. Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Dr. Antonio Cayatte provides comprehensive care for a broad spectrum of common health concerns, including:

  • Respiratory & ENT: acute bronchitis, concerns related to pneumonia, sinusitis, tonsillitis, ear infections, sore throat conditions, and allergic rhinitis
  • Eye Health: allergic and infectious conjunctivitis, as well as red or irritated eyes
  • Digestive & Urinary: gastroesophageal reflux disease (GERD), gastritis, urinary tract infections, and cystitis
  • Chronic Conditions: hypertension, elevated cholesterol, and structured weight management planning
0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

5.0 (194)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Get TARDYFERON 80 mg PROLONGED-RELEASE TABLETS Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for TARDYFERON 80 mg PROLONGED-RELEASE TABLETS?

TARDYFERON 80 mg PROLONGED-RELEASE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in TARDYFERON 80 mg PROLONGED-RELEASE TABLETS?

The active ingredient in TARDYFERON 80 mg PROLONGED-RELEASE TABLETS is ferrous sulfate. This information helps identify medicines with the same composition but different brand names.

How much does TARDYFERON 80 mg PROLONGED-RELEASE TABLETS cost in pharmacies?

The average pharmacy price for TARDYFERON 80 mg PROLONGED-RELEASE TABLETS is around 2.5 EUR. Prices may vary depending on the manufacturer and dosage form.

Who manufactures TARDYFERON 80 mg PROLONGED-RELEASE TABLETS?

TARDYFERON 80 mg PROLONGED-RELEASE TABLETS is manufactured by Pierre Fabre Iberica S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of TARDYFERON 80 mg PROLONGED-RELEASE TABLETS online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TARDYFERON 80 mg PROLONGED-RELEASE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy TARDYFERON 80 mg PROLONGED-RELEASE TABLETS in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy TARDYFERON 80 mg PROLONGED-RELEASE TABLETS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to TARDYFERON 80 mg PROLONGED-RELEASE TABLETS?

Other medicines with the same active substance (ferrous sulfate) include FERO-GRADUMET 105 mg PROLONGED-RELEASE TABLETS, FERBISOL 100 mg GASTRO-RESISTANT CAPSULES, FERRO SANOL 100 mg GASTRO-RESISTANT CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media